FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

385060002: Prolonged-release oral tablet (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3636013018 Prolonged-release oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module
3636014012 Prolonged-release oral tablet (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3636019019 Extended-release oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module

5 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release oral tablet Is a Tablet false Inferred relationship Existential restriction modifier
Prolonged-release oral tablet Is a Conventional release oral tablet false Inferred relationship Existential restriction modifier
Prolonged-release oral tablet Has dose form intended site Oral true Inferred relationship Existential restriction modifier
Prolonged-release oral tablet Is a Modified-release oral tablet true Inferred relationship Existential restriction modifier
Prolonged-release oral tablet Has dose form administration method Swallow true Inferred relationship Existential restriction modifier
Prolonged-release oral tablet Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Prolonged-release oral tablet Has dose form release characteristic Prolonged-release true Inferred relationship Existential restriction modifier
Prolonged-release oral tablet Has basic dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Sondate XL 300mg tablets (Teva UK Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Ebesque XL 300mg tablets (DB Ashbourne Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Zaluron XL 300mg tablets (Fontus Health Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Mintreleq XL 400mg tablets (CEB Pharma Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Psyquet XL 300mg tablets (Sandoz Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Brancico XL 200mg tablets (Zentiva Pharma UK Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Tenprolide XL 300mg tablets (Actavis UK Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Biquelle XL 300mg tablets (Aspire Pharma Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Psyquet XL 200mg tablets (Sandoz Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Seroquel XL 200mg tablets (Doncaster Pharmaceuticals Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Seotiapim XL 400mg tablets (Sandoz Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Ebesque XL 400mg tablets (DB Ashbourne Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Zaluron XL 200mg tablets (Fontus Health Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Zaluron XL 400mg tablets (Fontus Health Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Nevirapine 400mg modified-release tablets (Dr Reddy's Laboratories (UK) Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Seroquel XL 400mg tablets (Originalis B.V.) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier

Start Previous Page 5 of 5

This concept is not in any reference sets

Back to Start